产品
编 号：F102582
分子式：C33H50N4O6S
分子量：630.84
分子式：C33H50N4O6S
分子量：630.84
产品类型
规格
价格
是否有货
结构图
CAS No: 126222-34-2
产品详情
生物活性：
Remikiren (Ro 42-5892) is an orally active and highly specific renin inhibitor. Remikiren specifically inhibits human reninand human plasma renin with IC50 values of 0.7 and 0.8 nM, respectively. Remikiren also reduces mean arterial blood pressure in sodium-depleted marmosets and squirrel monkeys. Remikiren can be used in study of hypertension.
体内研究：
Remikiren (0.1, 0.3, 1, 3, 10 mg/kg; p.o.; single) reduces mean arterial blood pressure in a dose-dependent manner in sodium-depleted marmosets and squirrel monkeys.Remikiren (3 mg/kg; p.o.; single) shows the duration of blood pressure decrease more than 24 h in sodium-depleted marmosets.Animal Model:Marmosets and squirrel monkeys (sodium-depleted).
Dosage:0.1, 0.3, 1, 3, 10 mg/kg
Administration:Oral administration; single.
Result:Decreased mean arterial pressure (MAP) by 20-25 mm Hg when at 0.1 mg/kg.Reached the maximal decrease (30 mm Hg) of MAP with 1 mg/kg in marmosets.Decreasesd 35 mm Hg blood pressure with 3-10 mg/kg in squirrel monkeys.
Animal Model:Marmosets (sodium-depleted).
Dosage:3 mg/kg
Administration:Oral administration; single.
Result:Showed MAP fell by 30 mm Hg, which lasting more than 24 h.
体外研究：
Remikiren (0-10 nM; 1-3 h) displays a considerable specificity to inhibit renin.
Remikiren (Ro 42-5892) is an orally active and highly specific renin inhibitor. Remikiren specifically inhibits human reninand human plasma renin with IC50 values of 0.7 and 0.8 nM, respectively. Remikiren also reduces mean arterial blood pressure in sodium-depleted marmosets and squirrel monkeys. Remikiren can be used in study of hypertension.
体内研究：
Remikiren (0.1, 0.3, 1, 3, 10 mg/kg; p.o.; single) reduces mean arterial blood pressure in a dose-dependent manner in sodium-depleted marmosets and squirrel monkeys.Remikiren (3 mg/kg; p.o.; single) shows the duration of blood pressure decrease more than 24 h in sodium-depleted marmosets.Animal Model:Marmosets and squirrel monkeys (sodium-depleted).
Dosage:0.1, 0.3, 1, 3, 10 mg/kg
Administration:Oral administration; single.
Result:Decreased mean arterial pressure (MAP) by 20-25 mm Hg when at 0.1 mg/kg.Reached the maximal decrease (30 mm Hg) of MAP with 1 mg/kg in marmosets.Decreasesd 35 mm Hg blood pressure with 3-10 mg/kg in squirrel monkeys.
Animal Model:Marmosets (sodium-depleted).
Dosage:3 mg/kg
Administration:Oral administration; single.
Result:Showed MAP fell by 30 mm Hg, which lasting more than 24 h.
体外研究：
Remikiren (0-10 nM; 1-3 h) displays a considerable specificity to inhibit renin.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备